Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 29;12(1):10929.
doi: 10.1038/s41598-022-15131-8.

Importance of underweight in childhood bacterial meningitis in Finland, Latin America and Angola

Affiliations

Importance of underweight in childhood bacterial meningitis in Finland, Latin America and Angola

Irmeli Roine et al. Sci Rep. .

Abstract

Our objective was to explore the importance of underweight on the course of childhood bacterial meningitis (BM) at different study sites, because prior studies showed discrepant results. Using directly comparable, prospective data from three continents, weight-for-age z-scores (WAZ) were determined by WHO Anthro programs in children with BM in Finland (N = 318), LatAm (N = 580), and Angola (N = 780) and compared with data describing the admission, course, and outcome of BM. WAZ < -1 indicates underweight; either mild (< -1 to -2), moderate (< -2 to -3), or severe (< -3). The mean WAZ (SD) was 0.17 (1.17), -0.42 (1.53), and -1.36 (1.44), and the prevalence of moderate-severe underweight 2.8%, 12.6%, and 31.3%, in Finland, LatAm, and Angola, respectively. In univariate analysis, LatAm and Angola showed an association between lower WAZ and poorer condition on admission, slower recovery, and more deaths. In Finland, infrequent underweight limited meaningful analysis. In multivariate analysis of different variables for increasing the odds of death, severe underweight had lower odds compared to disease severity in Angola, but highest in LatAm. Thus, the apparent discrepancy in underweights´ importance for increasing deaths varied from primary to more secondary according to locally more prominent risks.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Distribution of weight-for-age z-scores in Finland, Latin America, and Angola.
Figure 2
Figure 2
Clinical course according to weight-for-age category in all patients. Ordinary: Daily improvement and diminishing irritability. No seizures after day 3 of treatment. No focal neurological signs at any time. Complicated: Fever (axillary temperature > 37.4 °C), or irritability over 5 days. Seizures after day 3 of treatment, or focal seizures any time. Focal neurological signs at any time. Another focus of infection. Causal micro-organism resistant to the administered antibiotic. Fatal: Death caused by bacterial meningitis.

Similar articles

References

    1. GBD 2016 Meningitis Collaborators Global, regional, and national, burden of meningitis 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1061–1082. doi: 10.1016/S1474-4422(18)30387-9. - DOI - PMC - PubMed
    1. Molyneux E, Riordan FAI, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann. Trop. Paediatr. 2006;26:29–37. doi: 10.1179/146532806X90583. - DOI - PubMed
    1. Peltola H, Anttila M, Renkonen O-V. The Finnish Study Group. Randomised comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis. Lancet. 1989;1:1281–1287. doi: 10.1016/S0140-6736(89)92685-8. - DOI - PubMed
    1. Kilpi T, Peltola H, Jauhiainen T, Kallio MJT. The Finnish study group Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Pediatr. Infect. Dis. J. 1995;14:270–278. doi: 10.1097/00006454-199504000-00005. - DOI - PubMed
    1. Peltola H, Roine I, Fernández J, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: A prospective, randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 2007;45:1277–1286. doi: 10.1086/522534. - DOI - PubMed

Publication types